Michael Gottlieb
Corporate Officer/Principal bei POINT Biopharma, Inc. (United States)
Profil
Michael Gottlieb is currently the Chief Commercial Officer at POINT Biopharma, Inc. in the United States.
Prior to this, he worked at Sanofi Canada, Inc. as the Head of Rare Diseases Franchise from 2017 to 2019.
He also briefly served as the Chief Commercial Officer at POINT Biopharma Global, Inc. in 2021.
Mr. Gottlieb has a graduate degree from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Aktive Positionen von Michael Gottlieb
| Unternehmen | Position | Beginn |
|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | 01.01.2020 |
Ehemalige bekannte Positionen von Michael Gottlieb
| Unternehmen | Position | Ende |
|---|---|---|
| POIT BIOP | Corporate Officer/Principal | 25.11.2021 |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 01.09.2019 |
Ausbildung von Michael Gottlieb
| University of Western Ontario | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Private Unternehmen | 2 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
